S&P 500   3,426.92 (-1.63%)
DOW   28,195.42 (-1.44%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
S&P 500   3,426.92 (-1.63%)
DOW   28,195.42 (-1.44%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
S&P 500   3,426.92 (-1.63%)
DOW   28,195.42 (-1.44%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
S&P 500   3,426.92 (-1.63%)
DOW   28,195.42 (-1.44%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
Log in
OTCMKTS:CVLB

Conversion Labs Stock Forecast, Price & News

$6.75
0.00 (0.00 %)
(As of 10/16/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.18
Now: $6.75
$6.98
50-Day Range
$0.97
MA: $1.53
$7.45
52-Week Range
$0.10
Now: $6.75
$2.14
Volume14,628 shs
Average Volume420,285 shs
Market Capitalization$503.73 million
P/E RatioN/A
Dividend YieldN/A
Beta1.1
Conversion Labs, Inc., an Internet-based direct response marketing company, licenses, acquires, creates, and sells various products to consumers worldwide. Its products include Shapiro MD, a shampoo, conditioner, and leave-in foamer for thicker fuller hair; iNR Wellness MD, a nutritional supplement for immune support; and PDF Simpli, a PDF conversion software. The company sells its products through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites inrwellness.com and shapiromd.com. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was incorporated in 1987 and is based in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous manufacturing industries
Sub-IndustryN/A
Current SymbolOTCMKTS:CVLB
CUSIPN/A
CIKN/A
Phone855-743-6478
Employees16

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$12.47 million
Book Value($0.02) per share

Profitability

Net Income$-3,140,000.00

Miscellaneous

Market Cap$503.73 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
$6.75
0.00 (0.00 %)
(As of 10/16/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CVLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Conversion Labs (OTCMKTS:CVLB) Frequently Asked Questions

How has Conversion Labs' stock price been impacted by Coronavirus (COVID-19)?

Conversion Labs' stock was trading at $0.1269 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CVLB stock has increased by 5,219.1% and is now trading at $6.75.
View which stocks have been most impacted by COVID-19
.

When is Conversion Labs' next earnings date?

Conversion Labs is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Conversion Labs
.

How were Conversion Labs' earnings last quarter?

Conversion Labs Inc (OTCMKTS:CVLB) issued its quarterly earnings results on Monday, August, 17th. The company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $9.09 million for the quarter.
View Conversion Labs' earnings history
.

Are investors shorting Conversion Labs?

Conversion Labs saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 7,300 shares, an increase of 32.7% from the September 15th total of 5,500 shares. Based on an average trading volume of 487,100 shares, the short-interest ratio is currently 0.0 days.
View Conversion Labs' Short Interest
.

Who are some of Conversion Labs' key competitors?

What other stocks do shareholders of Conversion Labs own?

Who are Conversion Labs' key executives?

Conversion Labs' management team includes the following people:
  • Mr. Justin Schreiber, CEO, Pres & Director (Age 36)
  • Mr. Stefan Galluppi, COO, Chief Technology Officer & Director (Age 32)
  • Dr. Joseph V. DiTrolio, Chief Medical Officer of North America & Director (Age 68)
  • Mr. Robert Kalkstein, Advisor to the CEO (Age 37)
  • Mr. Sean Fitzpatrick, Chief Acquisition Officer (Age 36)

What is Conversion Labs' stock symbol?

Conversion Labs trades on the OTCMKTS under the ticker symbol "CVLB."

How do I buy shares of Conversion Labs?

Shares of CVLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Conversion Labs' stock price today?

One share of CVLB stock can currently be purchased for approximately $6.75.

How big of a company is Conversion Labs?

Conversion Labs has a market capitalization of $503.73 million and generates $12.47 million in revenue each year. Conversion Labs employs 16 workers across the globe.

What is Conversion Labs' official website?

The official website for Conversion Labs is www.conversionlabs.com.

How can I contact Conversion Labs?

Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company can be reached via phone at 855-743-6478 or via email at [email protected]

This page was last updated on 10/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.